Association between convalescent plasma and the risk of mortality among patients with COVID-19: a meta-analysis [version 3; peer review: 2 approved]

• Main Authors: Shinta Oktya Wardhani, -, Jonny Karunia Fajar, -, Laksmi Wulandari, -, Gatot Soegiarto, -, Yeni Purnamasari, -, Anisa Asmiragani, -, Helnida Anggun Maliga, -, Muhammad Ilmawan, -, Gloriana Seran, -, Dheka Sapti Iskandar, -, Conchita Emiliana Ndapa, -, Viviana Hamat, -, Rafika Ajeng Wahyuni, -, Linda Oktaviana Suci Cyntia, -, Feronika Maryanti Maarang, -, Yosef Andrian Beo, -, Olivera Agnes Adar, -, Iraky Mardya Rakhmadhan, -, Emilia Tiara Shantikaratri, -, Ayu Sekarani Damana Putri, -, Rizqa Wahdini, -, Endang Pati Broto, -, Agnes Wanda Suwanto, -, Fredo Tamara, -, Aditya Indra Mahendra, -, Eden Suryoiman Winoto, -, Pratista Adi Krisna, -, Harapan, -
• 格式: Article PeerReviewed
• 語言: English; English; English; English; English
• 出版: Francis & Taylor 2021
• 主題: R Medicine (General); RC Internal medicine
• 在線閱讀: https://repository.unair.ac.id/118329/1/Karil%20Artikel%2018.pdf; https://repository.unair.ac.id/118329/2/2.%20TURNITIN_Artikel%2018.pdf; https://repository.unair.ac.id/118329/3/1.%20Full%20Text_Artikel%2018.pdf; https://repository.unair.ac.id/118329/7/1.Karil_18.pdf; https://repository.unair.ac.id/118329/8/4.%20Korespondensi_18.pdf; https://repository.unair.ac.id/118329/; https://f1000research.com/articles/10-64/v3; https://doi.org/10.12688/f1000research.36396.3

Background: Convalescent plasma (CCP) has been used for treating some infectious diseases; however, the efficacy of CCP in coronavirus disease 2019 (COVID-19) remains controversial. The aim of this research was to assess the efficacy of CCP as an adjunctive treatment in COVID-19 patients. Methods:...